Valereum Plc (AQU:VLRM)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 1.700
-0.050 (-2.86%)
At close: Oct 30, 2026
Valereum Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.26 | 0.1 | 0.02 | - | - | - | |
Revenue Growth | 1271.28% | 410.16% | - | - | - | - |
Cost of Revenue | 0.06 | 0.06 | - | - | - | - |
Gross Profit | 0.2 | 0.04 | 0.02 | - | - | - |
Selling, General & Admin | 2.32 | 2.48 | 1.7 | 1.88 | 2.06 | 1.86 |
Operating Expenses | 2.32 | 2.48 | 1.74 | 1.89 | 2.06 | 1.86 |
Operating Income | -2.12 | -2.45 | -1.72 | -1.89 | -2.06 | -1.86 |
Interest Expense | -0 | -0 | -0.01 | -0 | - | -0.01 |
Interest & Investment Income | 0.11 | 0 | 0.01 | 0.02 | 0.03 | 0.03 |
Currency Exchange Gain (Loss) | -0.05 | -0.03 | 0 | 0 | 0 | -0 |
Other Non Operating Income (Expenses) | -0.17 | -0.17 | 0.07 | 0.22 | - | - |
EBT Excluding Unusual Items | -2.23 | -2.65 | -1.65 | -1.65 | -2.03 | -1.84 |
Impairment of Goodwill | - | - | -0.36 | - | - | - |
Gain (Loss) on Sale of Investments | -9.16 | -4.02 | 1.97 | 1.3 | -2.21 | - |
Gain (Loss) on Sale of Assets | -0 | -0 | 0.07 | - | - | - |
Asset Writedown | -0.35 | -0.35 | -0.02 | - | - | - |
Pretax Income | -11.74 | -7.02 | 0 | -0.35 | -4.25 | -1.84 |
Earnings From Continuing Operations | -11.74 | -7.02 | 0 | -0.35 | -4.25 | -1.84 |
Net Income | -11.74 | -7.02 | 0 | -0.35 | -4.25 | -1.84 |
Net Income to Common | -11.74 | -7.02 | 0 | -0.35 | -4.25 | -1.84 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 355 | 206 | 138 | 92 | 75 | 60 |
Shares Outstanding (Diluted) | 355 | 206 | 138 | 92 | 75 | 60 |
Shares Change | 106.57% | 49.26% | 50.86% | 21.98% | 25.10% | 381.85% |
EPS (Basic) | -0.03 | -0.03 | 0.00 | -0.00 | -0.06 | -0.03 |
EPS (Diluted) | -0.03 | -0.03 | 0.00 | -0.00 | -0.06 | -0.03 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.35 | -1.93 | -2.2 | -1.24 | 0.02 | -1.74 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.02 | -0.01 | - | -0.03 |
Gross Margin | 76.17% | 35.94% | 100.00% | - | - | - |
Operating Margin | -800.38% | -2489.26% | -8939.30% | - | - | - |
Profit Margin | -4440.89% | -7139.20% | 16.72% | - | - | - |
Free Cash Flow Margin | -888.91% | -1965.32% | -11410.82% | - | - | - |
EBITDA | -2.11 | -2.45 | -1.72 | -1.88 | -2.02 | -1.83 |
D&A For EBITDA | 0 | 0 | 0 | 0.01 | 0.05 | 0.03 |
EBIT | -2.12 | -2.45 | -1.72 | -1.89 | -2.06 | -1.86 |